News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Elad Sharon: Another win for patients with ALL
Photo from Elad Sharon/X
Jul 25, 2024, 21:25

Elad Sharon: Another win for patients with ALL

Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared on X:

“Another win for NCI, NCI CTEP Clinical Research, ECOG-ACRIN Cancer Research Group, but especially for patients with ALL! Amazing results with Amgen’s blinatumomab and for immunotherapy! Already approved by FDA Oncology...”

Elad Sharon: Another win for patients with ALL

Source: Elad Sharon/X

ALL Amgen blinatumomab cancer ECOG-ACRIN Cancer Research Group Elad Sharon FDA Oncology immunotherapy NCI NCI CTEP Clinical Research OncoDaily Oncology
Special Coverage
Societies
Aug 10, 2025, 02:08
10 Must-Read Posts in Immuno-Oncology This Week
Voices
Aug 9, 2025, 22:35
Naoto T. Ueno: No Difference in pCR, but Better Disease Control With Anthracyclines in HER2+ IBC
Voices
Aug 9, 2025, 22:17
Chadi Nabhan: How We Approach Papillary Renal Cell Cancer in Less Than 10 Minutes
Voices
Aug 9, 2025, 21:55
Andrea Necchi: Exploratory Biomarker Analyses of Adjuvant Nivolumab in Urothelial Carcinoma
Career
Aug 9, 2025, 21:22
Tomás Dalotto-Moreno Awarded 2025 MONARCA Grant for Latin America - AACR
Voices
Aug 9, 2025, 21:21
Bishal Gyawali: This Has Always Been Our Bottom Line
Insight
Aug 9, 2025, 21:07
Sakditad Saowapa: The Importance of Early detection in Pancreatic Cancer
Voices
Aug 9, 2025, 20:51
Vivek Subbiah: It Takes a Village to Bring Cutting-Edge Care to All Patients
Insight
Aug 9, 2025, 20:05
ImmunoHistoFluorescence Method for Sub-Nuclear Protein Analysis in Tissue - Danish Cancer Institute
Voices
Aug 9, 2025, 19:54
Wee Joo Chng: Another Very Successful Asian Myeloma Network Masterclass
Voices
Aug 9, 2025, 19:53
Margaret Locke: Our Work on Expediting Molecular Testing for New NSCLC
Positive
Aug 9, 2025, 19:46
Bold EU Initiative Uniting Young People Affected by Cancer Across Europe - Youth Cancer Europe